Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction

References

• Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020;(October). doi:10.1038/s41579-020-00459-7
   Google Scholar
• Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):1–10. doi:10.1186/s13054-020-03120-0
   PubMed Web of Science ®Google Scholar
• Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32. doi:10.1016/j.cytogfr.2020.05.003
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Herbert JA, Mcnamara PS, Hedrich CM. COVID-19: immunology and treatment options. Clin Immunol J. 2020;215:108448. doi:10.1016/j.clim.2020.108448
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569–1578. doi:10.1016/S0140-6736(20)31022-9
   PubMed Web of Science ®Google Scholar
• Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382:2411–2418. doi:10.1056/nejmoa2012410
   PubMed Web of Science ®Google Scholar
• Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;1–9. Doi:10.1056/nejmoa2016638.
   Google Scholar
• Kumar G, Kumar D, Singh NP. Therapeutic approach against 2019-nCoV by inhibition of ACE-2 receptor. Drug Res (Stuttg). 2020. doi:10.1055/a-1275-0228
   Web of Science ®Google Scholar
• Raza A, Muhammad F, Bashir S, et al. Antiviral and immune boosting activities of different medicinal plants against Newcastle disease virus in poultry. Worlds Poult Sci J. 2015;71(3):523–532. doi:10.1017/S0043933915002147
   Web of Science ®Google Scholar
• Ganguly B, Umapathi V, Rastogi SK. Nitric oxide induced by Indian ginseng root extract inhibits Infectious Bursal Disease virus in chicken embryo fibroblasts in vitro. J Anim Sci Technol. 2018;60(1):4–8. doi:10.1186/s40781-017-0156-2
   PubMedGoogle Scholar
• Williams-Orlando C. Human immunodeficiency virus and herbal medicine. Altern Complement Ther. 2017;23(2):51–59. doi:10.1089/act.2017.29099.cwo
   Google Scholar
• Cai Z, Zhang G, Tang B, Liu Y, Fu X, Zhang X. Promising anti-influenza properties of active constituent of withania somnifera ayurvedic herb in targeting neuraminidase of H1N1 influenza: computational study. Cell Biochem Biophys. 2015;72(3):727–739. doi:10.1007/s12013-015-0524-9
   PubMed Web of Science ®Google Scholar
• Bale S, Venkatesh P, Sunkoju M, Godugu C. An adaptogen: withaferin a ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines. Front Pharmacol. 2018;9(MAR):1–16. doi:10.3389/fphar.2018.00248
   PubMedGoogle Scholar
• Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 2020. doi:10.1080/07391102.2020.1772108
   Web of Science ®Google Scholar
• Kumar V, Dhanjal JK, Bhargava P, et al. Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn. 2020. doi:10.1080/07391102.2020.1775704
   Google Scholar
• Balkrishna A, Pokhrel S, Singh H, et al. Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model. Drug Des Dev Ther. 2020.
   Web of Science ®Google Scholar
• Sinha K, Mishra N, Singh J, Khanuja S. Tinospora cordifolia (Guduchi), a reservoir plant for therapeutic applications: a review. Indian J Tradit Knowl. 2004;3(3):257–270.
   Google Scholar
• Pruthvish R, Gopinatha SM. Antiviral prospective of Tinospora cordifolia on HSV-1. Int J Curr Microbiol Appl Sci. 2018;7(1):3617–3624. doi:10.20546/ijcmas.2018.701.425
   Google Scholar
• Kalikar M, Thawani V, Varadpande U, Sontakke S, Singh R, Khiyani R. Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients. Indian J Pharmacol. 2008;40(3):107–110. doi:10.4103/0253-7613.42302
   PubMed Web of Science ®Google Scholar
• Akram M, Tahir IM, Shah SMA, et al. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: a systematic review. Phytother Res. 2018;32(5):811–822. doi:10.1002/ptr.6024
   PubMed Web of Science ®Google Scholar
• Singh S, Agrawal SS. Anti-asthmatic and anti-inflammatory activity of Ocimum sanctum. Int J Pharmacogn. 1991;29(4):306–310. doi:10.3109/13880209109082904
   Google Scholar
• Vinaya BLK, Kamdod MA, Swamy M, Swamy M. Bronchodilator activity of Ocimum sanctum Linn. (tulsi) in mild and moderate asthmatic patients in comparison with salbutamol: a single-blind cross-over study. Int J Basic Clin Pharmacol. 2017;6(3):511. doi:10.18203/2319-2003.ijbcp20170543
   Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Whitt MA. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virol Methods. 2010;169(2):365–374. doi:10.1007/978-3-030-57317-1_5
   PubMed Web of Science ®Google Scholar
• Rentsch MB, Zimmer G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One. 2011;6(10). doi:10.1371/journal.pone.0025858
   PubMed Web of Science ®Google Scholar
• Balkrishna A, Pokhrel S, Varshney A. Tinospora cordifolia (Giloy) may curb COVID-19 contagion: tinocordiside disrupts the electrostatic interactions between ACE2 and RBD. Comb Chem High Throughput Screen. 2020;23(1):1–12. doi:10.2174/1386207323666201110152615
   Google Scholar
• Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243:359–366. doi:10.1006/excr.1998.4172
   PubMed Web of Science ®Google Scholar
• Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020;53:13–24. doi:10.1016/j.cytogfr.2020.05.009
   PubMed Web of Science ®Google Scholar
• Yang J, Hooper WC, Phillips DJ, Talkington DF. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun. 2002;70(7):3649–3655. doi:10.1128/IAI.70.7.3649-3655.2002
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Q, Han T, et al. Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst. Cell Mol Immunol. 2015;12:633–644. doi:10.1038/cmi.2014.80
   PubMed Web of Science ®Google Scholar
• Crestani B, Cornillet P, Dehoux M, Rolland C, Guenounou M, Aubier M. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo: regulation by alveolar macrophage secretory products. J Clin Invest. 1994;94(2):731–740. doi:10.1172/JCI117392
   PubMed Web of Science ®Google Scholar
• Balkrishna A, Solleti SK, Verma S, Varshney A. Application of humanized zebrafish model in the suppression of SARS-CoV-2 spike protein induced pathology by tri-herbal medicine coronil via cytokine modulation. Molecules. 2020;25(21):5091. doi:10.3390/molecules25215091
   PubMed Web of Science ®Google Scholar
• Wang W, Ye L, Ye L, et al. Up-regulation of IL-6 and TNF-alfa induced by SARS-coronavirus spike protein in murine macrophages via NF-kB pathway. Virus Res. 2007;128:1–8. doi:10.1016/j.virusres.2007.02.007
   PubMed Web of Science ®Google Scholar
• Dosch SF, Mahajan SD, Collins AR. SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kB pathway in human monocyte macrophages in vitro. Virus Res. 2009;142:19–27. doi:10.1016/j.virusres.2009.01.005
   PubMed Web of Science ®Google Scholar
• Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53:19–25. doi:10.1016/j.immuni.2020.06.017
   PubMed Web of Science ®Google Scholar
• Buszko M, Park J, Verthelyi D, Sen R, Young HA, Rosenberg AS. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge. Nat Immunol. 2020;21(10):1146–1151. doi:10.1038/s41590-020-0779-1
   PubMed Web of Science ®Google Scholar
• Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16(10):1708–1717. doi:10.7150/ijbs.45538
   PubMed Web of Science ®Google Scholar
• Rastogi S, Narayan D, Harsh R. COVID-19 pandemic: a pragmatic plan for ayurveda intervention. J Ayurveda Integr Med. 2020. doi:10.1016/j.jaim.2020.04.002
   Web of Science ®Google Scholar
• Shree P, Mishra P, Selvaraj C, et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)–a molecular docking study. J Biomol Struct Dyn. 2020;1–14. Doi:10.1080/07391102.2020.1810778.
   Google Scholar
• Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathulla AS, Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J Biomol Struct Dyn. 2020;1–14. doi:10.1080/07391102.2020.1790425
   Google Scholar
• Sagar V, Kumar AH. Efficacy of natural compounds from tinospora cordifolia against SARS-CoV-2 protease, surface glycoprotein and RNA polymerase. Biol Eng Med Sci Rep. 2020;6(1):6–8. doi:10.5530/bems.6.1.2
   Google Scholar
• Chowdhury P. In silico investigation of phytoconstituents from Indian medicinal herb “Tinospora cordifolia (giloy)” against SARS-CoV-2 (COVID-19) by molecular dynamics approach. J Biomol Struct Dyn. 2020;1–18. doi:10.1080/07391102.2020.1803968
   Web of Science ®Google Scholar
• Carino A, Moraca F, Fiorillo B, et al. Hijacking SARS-CoV-2/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on the receptor binding domain. Front Chem. 2020;8:1–26. doi:10.3389/fchem.2020.572885
   PubMed Web of Science ®Google Scholar
• Pavlova NI, Savinova OV, Nikolaeva SN, Boreko EI, Flekhter OB. Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia. 2003;74(5):489–492. doi:10.1016/S0367-326X(03)00123-0
   PubMed Web of Science ®Google Scholar
• Lai W, Huang L, Ho P, Li Z, Montefiori D, Chen CH. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2008;52(1):128–136. doi:10.1128/AAC.00737-07
   PubMed Web of Science ®Google Scholar
• Hong EH, Song JH, Kang KB, Sung SH, Ko HJ, Yang H. Anti-influenza activity of betulinic acid from Zizyphus Jujuba on influenza A/PR/8 virus. Biomol Ther. 2015;23(4):345–349. doi:10.4062/biomolther.2015.019
   PubMed Web of Science ®Google Scholar
• Tohmé MJ, Giménez MC, Peralta A, Colombo MI, Delgui LR. Ursolic acid: a novel antiviral compound inhibiting rotavirus infection in vitro. Int J Antimicrob Agents. 2019;54(5):601–609. doi:10.1016/j.ijantimicag.2019.07.015
   PubMed Web of Science ®Google Scholar
• Lin WY, Yu YJ, Jinn TR. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol J. 2019;16(1):1–9. doi:10.1186/s12985-019-1203-z
   PubMedGoogle Scholar
• Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007;51(9):3367–3370. doi:10.1128/AAC.00041-07
   PubMed Web of Science ®Google Scholar
• Yan Y, Shen X, Cao Y, Zhang J, Wang Y. Discovery of anti-2019-nCoV agents from 38 Chinese patent drugs toward respiratory diseases via docking screening. Preprints. 2020. doi:10.20944/preprints202002.0254.v2
   Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19. doi:10.1016/j.cell.2020.06.043
   PubMed Web of Science ®Google Scholar
• Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv Prepr Serv Biol. 2020. doi:10.1101/2020.06.12.148726
   Google Scholar
• Padhi AK, Tripathi T. Can SARS-CoV-2 accumulate mutations in the S-protein to increase pathogenicity? ACS Pharmacol Transl Sci. 2020;17–20. doi:10.1021/acsptsci.0c00113
   Google Scholar
• Ou J, Zhou Z, Dai R, et al. Emergence of RBD mutations in circulating SARS-CoV-2 strains enhancing the structural stability and human ACE2 receptor affinity of the spike protein. bioRxiv. 2020;1–30. Doi:10.1101/2020.03.15.991844.
   Google Scholar
• Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2- expressing cells. Proc Natl Acad Sci U S A. 2020;117(13):7001–7003. doi:10.1073/pnas.2002589117
   PubMed Web of Science ®Google Scholar
• Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol. 2020;101(9):925–940. doi:10.1099/jgv.0.001453
   PubMed Web of Science ®Google Scholar
• Harcourt J, Tamin A, Lu X, et al. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis. 2020;26(6):1266–1273. doi:10.3201/EID2606.200516
   PubMed Web of Science ®Google Scholar
• Butterweck H, Weber A. A potential mechanism for triggering cytokine storm in Covid-19 patients. COJ Biomed Sci Res. 2020;1(2):COJBSR.000508.
   Google Scholar